BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tai TY, Lu JY, Chen CL, Lai MY, Chen PJ, Kao JH, Lee CZ, Lee HS, Chuang LM, Jeng YM. Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C. J Endocrinol. 2003;178:457-465. [PMID: 12967337 DOI: 10.1677/joe.0.1780457] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Du L, Tang H. Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection. Front Med (Lausanne) 2021;8:784172. [PMID: 34901094 DOI: 10.3389/fmed.2021.784172] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Cai Q, Liu H, Han W, Liu L, Xu Y, He Y, Li Q, Zhang M, Hu A, Zheng Y. Maternal HBsAg carriers and adverse pregnancy outcomes: A hospital-based prospective cohort analysis. J Viral Hepat 2019;26:1011-8. [PMID: 30972911 DOI: 10.1111/jvh.13105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Newby BN, Mathews CE. Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment. Front Endocrinol (Lausanne) 2017;8:232. [PMID: 28959234 DOI: 10.3389/fendo.2017.00232] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
4 Davis TME, Davis WA, Jeffrey G. Successful Withdrawal of Insulin Therapy After Post-Treatment Clearance of Hepatitis C Virus in a Man with Type 2 Diabetes. Am J Case Rep 2017;18:414-7. [PMID: 28413215 DOI: 10.12659/ajcr.903600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Chien CH, Lin CL, Hu CC, Chang JJ, Chien RN. Clearance of Hepatitis C Virus Improves Insulin Resistance During and After Peginterferon and Ribavirin Therapy. J Interferon Cytokine Res. 2015;35:981-989. [PMID: 26308911 DOI: 10.1089/jir.2014.0200] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
6 Huang JF, Yu ML, Dai CY, Chuang WL. Glucose abnormalities in hepatitis C virus infection. Kaohsiung J Med Sci. 2013;29:61-68. [PMID: 23347806 DOI: 10.1016/j.kjms.2012.11.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
7 Lao TT, Sahota DS, Suen SSH, Law LW, Leung TY. Maternal HBsAg status and infant size - a Faustian bargain?: Higher birthweight in maternal HBV infection. Journal of Viral Hepatitis 2012;19:519-24. [DOI: 10.1111/j.1365-2893.2011.01575.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
8 Huang JF, Dai CY, Yu ML, Huang CF, Huang CI, Yeh ML, Yang JF, Hou NJ, Hsiao PJ, Lin ZY. Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patients. Liver Int. 2011;31:1155-1162. [PMID: 21745292 DOI: 10.1111/j.1478-3231.2011.02545.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
9 Hwang SJ, Lee SD. Hepatic steatosis and hepatitis C: Still unhappy bedfellows? J Gastroenterol Hepatol. 2011;26 Suppl 1:96-101. [PMID: 21199519 DOI: 10.1111/j.1440-1746.2010.06542.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
10 Conjeevaram HS, Wahed AS, Afdhal N, Howell CD, Everhart JE, Hoofnagle JH;  Virahep-C Study Group. Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. Gastroenterology. 2011;140:469-477. [PMID: 21070775 DOI: 10.1053/j.gastro.2010.11.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
11 Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI. Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin Resistance. Gut Liver. 2009;3:108-115. [PMID: 20431732 DOI: 10.5009/gnl.2009.3.2.108] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
12 Machado MV, Cortez-pinto H. Insulin resistance and steatosis in chronic hepatitis C. Annals of Hepatology 2009;8:S67-75. [DOI: 10.1016/s1665-2681(19)31829-0] [Cited by in Crossref: 25] [Article Influence: 1.9] [Reference Citation Analysis]
13 Lv YY, Shi BY, Guo H. Abrupt onset of type 1 diabetes mellitus during recombinant interferon-alpha 2b therapy in a patient with chronic hepatitis B. World J Gastroenterol 2008; 14(29): 4713-4715 [PMID: 18698691 DOI: 10.3748/wjg.14.4713] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
14 Ishizaka N, Ishizaka Y, Seki G, Nagai R, Yamakado M, Koike K. Association between hepatitis BC viral infection, chronic kidney disease and insulin resistance in individuals undergoing general health screening. Hepatology Research 2008;38:775-83. [DOI: 10.1111/j.1872-034x.2008.00334.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
15 Zhang WY, Zhang JQ, Wang Q, Li GL, Wang XC, Zhang CY, Yang D, Cheng J. Screening of proteins binding to hepatitis B core antigen from human pancreas cDNA library by yeast two-hybrid system. Shijie Huaren Xiaohua Zazhi 2008; 16(16): 1746-1750 [DOI: 10.11569/wcjd.v16.i16.1746] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Nylen ES, Marathe IC, Khan IA, Azevedo R, Hirsch KR. Sudden onset of diabetic ketoacidosis during consensus interferon therapy for chronic viral hepatitis C. Am J Med Sci 2008;335:329-30. [PMID: 18414077 DOI: 10.1097/MAJ.0b013e318145a721] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
17 Donath MY, Størling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T. Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev. 2008;29:334-350. [PMID: 18048762 DOI: 10.1210/er.2007-0033] [Cited by in Crossref: 148] [Cited by in F6Publishing: 146] [Article Influence: 9.9] [Reference Citation Analysis]
18 Schreuder TC, Gelderblom HC, Weegink CJ, Hamann D, Reesink HW, Devries JH, Hoekstra JB, Jansen PL. High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection. Liver Int. 2008;28:39-46. [PMID: 18031478 DOI: 10.1111/j.1478-3231.2007.01610.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
19 Lo Iacono O, Venezia G, Petta S, Mineo C, De Lisi S, Di Marco V, Rodolico V, Amato M, Ferraro D, Giordano C. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2007;25:1181-1191. [PMID: 17451564 DOI: 10.1111/j.1365-2036.2007.03309.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
20 Lonardo A, Carulli N, Loria P. HCV and diabetes. A two-question-based reappraisal. Dig Liver Dis. 2007;39:753-761. [PMID: 17611176 DOI: 10.1016/j.dld.2007.05.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
21 Huang JF, Dai CY, Hwang SJ, Ho CK, Hsiao PJ, Hsieh MY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Shin SJ, Chang WY, Chuang WL, Yu ML. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am J Gastroenterol 2007;102:1237-43. [PMID: 17531012 DOI: 10.1111/j.1572-0241.2007.01181.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 5.9] [Reference Citation Analysis]
22 Lao TT, Chan BC, Leung WC, Ho LF, Tse KY. Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol. 2007;47:46-50. [PMID: 17434231 DOI: 10.1016/j.jhep.2007.02.014] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 4.7] [Reference Citation Analysis]
23 Romero-Gómez M. Insulin resistance and hepatitis C. World J Gastroenterol. 2006;12:7075-7080. [PMID: 17131467 DOI: 10.1111/j.1478-3231.2010.02365.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
24 Soultati AS, Dourakis SP, Alexopoulou A, Deutsch M, Archimandritis AJ. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C. World J Gastroenterol 2007; 13(8): 1292-1294 [PMID: 17451219 DOI: 10.3748/wjg.v13.i8.1292] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
25 Mello V, Cruz T, Nuñez G, Simões MT, Ney-Oliveira F, Braga H, Araújo C, Cunha S, Schinoni MI, Cruz M, Parana R. Peripheral insulin resistance during treatment of chronic hepatitis C with peguilated interferon plus ribavirin. J Med Virol 2006;78:1406-10. [PMID: 16998879 DOI: 10.1002/jmv.20712] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
26 Romero-Gómez M. Insulin resistance and hepatitis C. World J Gastroenterol 2006; 12(44): 7075-7080 [PMID: 17131467 DOI: 10.3748/wjg.v12.i44.7075] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 103] [Article Influence: 7.0] [Reference Citation Analysis]
27 Tahrani A, Bowler L, Singh P, Coates P. Resolution of diabetes in type 2 diabetic patient treated with IFN-alpha and ribavirin for hepatitis C. Eur J Gastroenterol Hepatol. 2006;18:291-293. [PMID: 16462544 DOI: 10.1097/00042737-200603000-00011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
28 Greenberg PD, Rosman AS, Eldeiry LS, Naqvi Z, Brau N. Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C*. J Viral Hepat 2006;13:613-7. [DOI: 10.1111/j.1365-2893.2006.00729.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
29 Lu J, Chuang L, Yang W, Tai T, Lai M, Chen P, Kao J, Lee C, Lee H. Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy. Liver Int 2005;25:752-9. [DOI: 10.1111/j.1478-3231.2005.1007.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
30 Romero-gómez M, Del Mar Viloria M, Andrade RJ, Salmerón J, Diago M, Fernández-rodríguez CM, Corpas R, Cruz M, Grande L, Vázquez L, Muñoz-de-rueda P, López-serrano P, Gila A, Gutiérrez ML, Pérez C, Ruiz-extremera A, Suárez E, Castillo J. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005;128:636-41. [DOI: 10.1053/j.gastro.2004.12.049] [Cited by in Crossref: 536] [Cited by in F6Publishing: 492] [Article Influence: 31.5] [Reference Citation Analysis]